Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Trilivy, a metabolic health system by Medifast, identifies five key factors that drive weight regain: slowed metabolism, hormonal changes, lack of human support, set point theory, and metabolic adaptation. The company's Metabolic Synchronization® framework addresses these through lean mass preservation and visceral fat reduction, with clinical data showing 98% lean mass retention and 14% visceral fat reduction at 16 weeks.
Monster Beverage's international sales jumped 34.6% to $1.16B in Q2 2026, now representing 46% of total sales. Strong growth in EMEA (27.2%), Asia-Pacific (35.7%), and Latin America (56.1%) is driven by product innovation, cooler placements, and Coca-Cola bottler partnerships. However, lower overseas margins and inflation in aluminum, freight, and fuel pose challenges. The stock trades at a premium 36.59X forward P/E, well above the industry average of 19.32X.
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came out today.